Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status  Phase of research How it helps Latest publication
Metformin glycinate
Potential treatment - clinical evidence Used to treat other disease Other treatment
Sitagliptin
Potential treatment - clinical evidence Used to treat other disease Other treatment
Angiotensin-converting enzyme inhibitors
Potential treatment - clinical evidence Used to treat other disease Other treatment
Angiotensin receptor blockers
Potential treatment - clinical evidence Used to treat other disease Other treatment
Dipeptidyl peptidase-4 inhibitor
Potential treatment - clinical evidence Used to treat other disease Other treatment
Cobimetinib
Potential treatment - pre-clinical evidence Used to treat other disease Other treatment Sep/06/2021
CC12.1
Potential treatment - pre-clinical evidence Experimental Antiviral
Ponatinib
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Sep/06/2021
mAb 222
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/04/2022
mAb Beta-55
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/04/2022
COVA1-16
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/08/2021
mAb Beta-29
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/04/2022
MVC-COV1901
Potential treatment - pre-clinical evidence Experimental Vaccine Nov/29/2020
S96
Potential treatment - pre-clinical evidence Experimental Antiviral
PCI-27483
Potential treatment - pre-clinical evidence Experimental Antiviral Apr/12/2021
Tannic acid
Potential treatment - pre-clinical evidence Natural product Antiviral Mar/30/2021
mAb Beta-22
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/27/2021
NSC Ex/Mv
Potential treatment - pre-clinical evidence Experimental Antiviral Dec/18/2020
Antipain
Potential treatment - pre-clinical evidence Natural product Antiviral Apr/12/2021
Y-320
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/23/2021